Researchers have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease.
5d
News-Medical.Net on MSNIL-12 targeting could open pathways for new Alzheimer's treatmentsResearchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's ...
4d
News Medical on MSNCD2AP and Alzheimer’s disease: A key regulator of neurodegeneration and potential therapeutic targetA comprehensive Thought Leaders Invited Review in Brain Medicine highlights the crucial role of CD2-associated protein (CD2AP ...
The results boost hopes similar treatments being developed to target more common forms of Alzheimer’s – that appear when ...
Ever since Austrian scientists first began looking for them in people in 2018, microplastics have turned up in the blood, ...
But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...
Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...
Discover 3 benefits of pomegranates, from heart health protection and powerful antioxidant effects to enhanced athletic ...
The companies, now engaged in a research collaboration to prove their technology’s combined efficiency, will potentially move forward to create a for-research kit marketed to pharmaceutical companies ...
The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...
Vaccination against shingles may reduce dementia risk, suggesting viral infections play a crucial role in Alzheimer’s disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results